Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum
Clinical Trials as Topic
Urinary Bladder Neoplasms
The meeting provided a unique opportunity to launch a collective effort to establish molecular-based therapies for muscle-invasive urothelial cancer. The goal is to use this framework to develop comparable trials with immunotherapy in non-muscle invasive cancers and to exploit the neoadjuvant platform to develop targeted therapy in muscle-invasive disease.